Skip to main content
SpringerLink
Log in

Study Design and Methodologies for Study of Ocular Medical Devices

  • Protocol
  • First Online:
Ocular Pharmacology and Toxicology

Part of the book series: Methods in Pharmacology and Toxicology ((MIPT))

  • 1527 Accesses

Abstract

This chapter focuses on the test methods necessary to demonstrate the safety and “biocompatibility” of ocular medical devices. Biocompatibility has a variety of definitions, but in general it is the quality of the medical device or biomaterial to not have toxic, adverse, or injurious effects on biological systems. The test methods described in this chapter are the commonly used routine test methods for establishing biocompatibility.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. ISO 10993–1:2009. Biological evaluation of medical devices—Part 1: evaluation and testing within a risk management process, ISO, Geneva, Switzerland, 2009

    Google Scholar 

  2. ISO 10993–2:2006. Biological evaluation of medical devices— Part 2: animal welfare requirements, ISO, Geneva, Switzerland, 2006

    Google Scholar 

  3. ISO 10993–3:2003. Biological evaluation of medical devices—Part 3: tests for genotoxicity, carcinogenicity and reproductive toxicity, ISO, Geneva, Switzerland, 2003

    Google Scholar 

  4. ISO 10993–4:2002/Amd 1:2006. Biological evaluation of medical devices—Part 4: selection of tests for interactions with blood. ISO, Geneva, Switzerland, 2002, 2006

    Google Scholar 

  5. ISO 10993–5:2009. Biological evaluation of medical devices—Part 5: tests for in vitro cytotoxicity, ISO, Geneva, Switzerland, 2009

    Google Scholar 

  6. ISO 10993–6:2007. Biological evaluation of medical devices—Part 6: tests for local effects after implantation, ISO, Geneva, Switzerland, 2007

    Google Scholar 

  7. ISO 10993–10:2010. Biological evaluation of medical devices—Part 10: tests for irritation and skin sensitization, ISO, Geneva, Switzerland, 2010

    Google Scholar 

  8. ISO 10993–11:2006. Biological evaluation of medical devices—Part 11: tests for systemic toxicity, ISO, Geneva, Switzerland, 2006

    Google Scholar 

  9. ISO 10993–12:2012. Biological evaluation of medical devices—Part 12: sample preparation and reference materials, ISO, Geneva, Switzerland, 2012

    Google Scholar 

  10. ISO 10993–16:2010. Biological evaluation of medical devices—Part 16: toxicokinetic study design for degradation products and leachables, ISO, Geneva, Switzerland, 2010

    Google Scholar 

  11. ISO 9394:1998, Ophthalmic optics – Contact lenses and contact lens care products—determination of biocompatibility by ocular study with rabbit eyes, ISO, Geneva, Switzerland, 2011

    Google Scholar 

  12. ISO 11979–5:2006(E). Ophthalmic implants—intraocular lenses—Part 5: biocompatibility, ISO, Geneva, Switzerland, 2006

    Google Scholar 

  13. ISO 15798: 2009(E). Ophthalmic implants—ophthalmic viscosurgical devices, ISO Geneva, Switzerland, 2009

    Google Scholar 

  14. OECD Guidelines for the Testing of Chemicals. Test No. 406: Skin sensitization. OECD, Paris, France, 1992

    Google Scholar 

  15. OECD Guidelines for the Testing of Chemicals. Test No. 429: Skin sensitization: local Lymph Node Assay. OECD, Paris, France, 2010

    Google Scholar 

  16. Ryan CA, Cruse LW, Skinner RA, Dearman RJ, Kimber I, Gerberick GF (2002) Examination of a vehicle for use with water soluble materials in the murine local lymph node assay. Food Chem Toxicol 40:1719–1725

    Article  PubMed  CAS  Google Scholar 

  17. OECD Guidelines for the Testing of Chemicals. Test No. 405: Acute eye irritation/corrosion. OECD, Paris, France, 2012

    Google Scholar 

  18. United States Pharmacopeia. General chapter <88> biological reactivity tests, in vivo. Rockville, MD, USA, 2013

    Google Scholar 

  19. OECD Guidelines for the Testing of Chemicals. Test No. 471: Bacterial reverse mutation test. OECD, Paris, France, 1997

    Google Scholar 

  20. OECD Guidelines for the Testing of Chemicals. Test No. 476: In vitro mammalian cell gene mutation test. OECD, Paris, France, 1997

    Google Scholar 

  21. OECD Guidelines for the Testing of Chemicals. Test No. 473: In vitro mammalian cell Chromosomal Aberration Test. OECD, Paris, France, 1997

    Google Scholar 

  22. OECD Guidelines for the Testing of Chemicals. Test No. 474: Mammalian erythrocyte micronucleus test. OECD, Paris, France, 1997

    Google Scholar 

  23. OECD Guidelines for the Testing of Chemicals. Test No. 475: Mammalian bone marrow chromosome aberration test. OECD, Paris, France, 1997

    Google Scholar 

  24. ISO 14971:2007. Medical devices—application of risk management to medical devices, ISO, Geneva, Switzerland, 2007

    Google Scholar 

  25. Guidance for Industry and for the US FDA Reviewers and Staff. Aqueous Shunts—501(k) Submissions, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiologic Health. November 16, 1998

    Google Scholar 

  26. Code of Federal Regulations, Title 21, Volume 8, Chapter I, Subchapter H, Part 886 Ophthalmic Devices, April, 2012

    Google Scholar 

  27. Code of Federal Regulations, Title 21, Volume 1, Subchapter 1, Part 3.2 Definitions, April 2012

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. NAMSA, Northwood, OH, USA

    Joseph W. Carraway & Elaine M. Daniel

Authors
  1. Joseph W. Carraway
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elaine M. Daniel
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA

    Brian C. Gilger

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this protocol

Cite this protocol

Carraway, J.W., Daniel, E.M. (2013). Study Design and Methodologies for Study of Ocular Medical Devices. In: Gilger, B. (eds) Ocular Pharmacology and Toxicology. Methods in Pharmacology and Toxicology. Humana Press, Totowa, NJ. https://doi.org/10.1007/7653_2013_4

Download citation

  • DOI: https://doi.org/10.1007/7653_2013_4

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-744-0

  • Online ISBN: 978-1-62703-745-7

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation